XML 31 R24.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Revenue (Tables)

6 Months Ended

Jun. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

		Three Months Ended June 30,								Six Months Ended June 30,
		2024				2023				2024				2023
MRD revenue
Service revenue		$	32,284			$	25,882			$	60,410			$	47,309
Regulatory milestone revenue			3,000				—				7,500				—
Total MRD revenue			35,284				25,882				67,910				47,309
Immune Medicine revenue
Service revenue			6,148				5,508				10,707				12,610
Collaboration revenue			1,758				17,536				6,446				26,654
Total Immune Medicine revenue			7,906				23,044				17,153				39,264
Total revenue		$	43,190			$	48,926			$	85,063			$	86,573

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration